stockrowTeleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) EPS (diluted)
Teleflex Incorporated's EPS (diluted) for fiscal 2025 was −$20.25, compared with $1.48 in fiscal 2024. Over the twelve months to 30 June 2026 it was −$23.29. Over the past ten years it has ranged from −$20.25 (fiscal 2025) to $10.23 (fiscal 2021) — the current reading is the lowest in ten years. EPS (diluted) has fallen for 4 consecutive fiscal years. Teleflex Incorporated ranks 47th of 47 Medical Instruments & Supplies companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$20.25 | — |
| FY2024 | $1.48 | (80.35%) |
| FY2023 | $7.53 | (1.95%) |
| FY2022 | $7.68 | (24.93%) |
| FY2021 | $10.23 | 44.29% |
| FY2020 | $7.09 | (27.65%) |
| FY2019 | $9.80 | 128.44% |
| FY2018 | $4.29 | 31.19% |
| FY2017 | $3.27 | (34.34%) |
| FY2016 | $4.98 | (2.35%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $2.28 | — |
| Mar 2026 | −$0.18 | — |
| Dec 2025 | −$16.15 | — |
| Sep 2025 | −$9.24 | — |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| ATR AptarGroup, Inc. compare | $4.12 |
| NVST Envista Holdings Corporation compare | $3.92 |
| MMSI Merit Medical Systems, Inc. compare | $2.66 |
| ICUI ICU Medical, Inc. compare | $2.39 |
| AVTR Avantor, Inc. compare | $0.50 |
| BLCO Bausch + Lomb Corporation compare | −$0.30 |
| MMED MiniMed Group, Inc. compare | −$0.59 |
| PLSE Pulse Biosciences, Inc compare | −$1.21 |
| TFX Teleflex Incorporated | −$23.29 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on TFX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement